New skin grafts aim to heal stubborn ulcers faster

NCT ID NCT06515093

Recruiting now Disease control Sponsor: Surgenex Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two types of skin grafts (PelloGraft and SanoGraft) to standard wound care for healing diabetic foot ulcers and venous leg ulcers. About 180 adults with chronic wounds will be enrolled. The goal is to see if these grafts help wounds close completely within 12 to 16 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PelloGraft (dual layer amnion/chorion allograft) and SanoGraft (single layer amnion allograft)
What this could lead to: If successful, these grafts could become a standard treatment to help diabetic foot and venous leg ulcers heal faster and more completely.
What could go wrong: This is a post-market study, not a large Phase 3 trial. Results may not apply to all patients, and some ulcers may not heal despite treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetic Foot ulcer of lower limbs Varicose Ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC FOOT ULCER VENOUS LEG ULCER

Contacts and locations

Locations

ILD Research
RECRUITING

Vista, California, 92801, United States
Tulsa Wound Center
RECRUITING

Tulsa, Oklahoma, 74135, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.